The Frequency of Phospholipid Antibodies in an Unselected Stroke Population

Canadian Journal of Neurological Sciences - Tập 25 Số 1 - Trang 64-69 - 1998
L Metz1, Steven M. Edworthy1, R. Mydlarski1, Fritzler Mj1
1Department of Clinical Neurosciences, Foothills Hospital, University of Calgary

Tóm tắt

ABSTRACT:Background:Antibodies to cardiolipin and other phospholipids have been associated with recurrent thrombotic events, including stroke.Methods:Over a 16 month period we assessed an unselected cohort of 151 ischemic stroke patients for the presence of antiphospholipid antibodies. Patients with known systemic lupus erythematosis, systemic sclerosis, or Sjogrens Syndrome were excluded. Sera from patients admitted to hospital with a diagnosis of ischemic stroke (n = 151) and from controls (n = 111) assessed during the same period were tested for antiphospholipid antibodies (APLA) using 3 assays; anticardiolipin antibodies (ACA) by ELISA, prolonged activated partial thromboplastin time (APTT), and VDRL.Results:The average age of ischemic stroke cases was 68 years (range 29 to 91) and of controls 63 years (range 29 to 86). The prevalence of APLA detected by at least one of the three methods was 12% for IS cases and 10% for controls. After correcting for known risk factors such as age, gender, diabetes mellitus, heart disease, hypertension, and smoking, the odds ratio for risk of stroke fell to 0.8 (C.I. 0.4 to 1.2).Conclusions:Our findings suggest that APLA may not be an independent risk factor for ischemic stroke in unselected persons who do not have known systemic lupus erythematosis or systemic sclerosis but further evaluation of the role of lupus anticoagulant is indicated.

Từ khóa


Tài liệu tham khảo

Altman, 1991, 169

10.1016/0140-6736(90)91374-J

10.1212/WNL.40.8.1190

10.1212/WNL.43.10.2069

10.1016/0090-1229(85)90045-5

Ginsberg, 1995, Antiphospholipid antibodies and venous thromboembolism, Blood, 86, 3685, 10.1182/blood.V86.10.3685.bloodjournal86103685

10.1006/clin.1994.1128

10.1161/01.STR.23.2.189

10.1161/01.STR.22.6.750

10.1016/0002-9343(90)90523-G

10.1212/WNL.41.4.525

1986, Causes of Death Vital Statistics, 4, 84

Sahs, 1973, Stroke: Cause, Prevention, Treatment and Rehabilitation, 1

10.1002/ana.410250303

10.1161/01.STR.21.2.295

Chakravarty, 1991, Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus, Q J Med, 397

Ginsberg, 1992, Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis, Ann Intern Med, 117, 997, 10.7326/0003-4819-117-12-997

10.1001/archneur.1987.00520200078024

Fields, 1989, The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies, J Rheumatol, 16, 623

Harris, 1986, Evaluation of the anticardiolipin antibody test: report of a standardization workshop held April 4, Clin Exp Rheumatol, 3, 349

Larsen, 1990, A Manual of Tests for Syphilis, 77

10.1073/pnas.87.11.4120

Thông tin
Thông tin xuất bản

Canadian Journal of Neurological Sciences

Tập 25 Số 1

64-69

Thông tin tác giả